Model-driven design allows growth of Mycoplasma pneumoniae on serum-free media

Area of Science:

• Microbiology
• Systems Biology
• Metabolic Engineering

Background:

• Mycoplasma pneumoniae causes atypical pneumonia and is difficult to cultivate due to its fastidious nature and lack of a cell wall.
• Current cultivation methods rely on undefined, rich media, posing challenges for large-scale production and cost-efficiency.
• Understanding M. pneumoniae's metabolic limitations is crucial for improving its cultivation and studying the pathogen.

Purpose of the Study:

• To develop a genome-scale metabolic model (iEG158_mpn) for Mycoplasma pneumoniae.
• To identify key factors limiting bacterial growth, with a focus on cell membrane formation.
• To predict and validate essential medium components for growth in defined, serum-free conditions.

Main Methods:

• Construction of a genome-scale, constraint-based metabolic model (iEG158_mpn) for M. pneumoniae.
• In silico analysis focusing on lipid metabolism and cell membrane synthesis.
• In vitro validation of predicted essential nutrients in serum-free media.

Main Results:

• The metabolic model successfully predicted essential components for M. pneumoniae growth.
• Optimized medium composition enabled growth in defined, serum-free conditions.
• Hypoxia was found to significantly reduce the efficiency of glycolysis and lipid metabolism.

Conclusions:

• Metabolic modeling provides a powerful approach to understand and overcome cultivation challenges for fastidious bacteria like M. pneumoniae.
• The developed model and optimized medium facilitate stable, reproducible, and less expensive large-scale production.
• Further research is needed to explore factors beyond metabolism and membrane formation that influence M. pneumoniae growth, particularly under hypoxic conditions.